FDA Adverse Event Malfunction Summary report: N

SPINA

MDR report key: 412242 · Received August 20, 2002

Report

Report Number
MW1025918
Event Type
Malfunction
Date Received
August 20, 2002
Report Date
August 20, 2002
Manufacturer
NORTH AMERICAN MEDICAL CORP
Product Code
ITH
Product Problem
Yes
Report Source
Voluntary report
Reporter Location
NJ, US
Reporter Occupation
PHYSICIAN

Narratives

Description of Event or Problem · 1

RPTR IS A PRACTICING ORTHOPAEDIC SURGEON. RPTR HAS RECEIVED A MAILING FROM DR OF NORTH AMERICAN MEDICAL CORP REGARDING SPINA (510K APPROVED), INDICATING HOW MUCH MONEY RPTR COULD EARN BY USING IT. THE CLAIMS INCLUDED RELIEF FROM HERNIATED DISCS. THE DEVICE SEEMS SIMILAR TO THE VAX-D, AND RPTR KNOWS THAT FDA TOOK ACTION AGAINST THEM FOR SIMILAR CLAIMS, NOT COVERED BY THE 510K APPROVAL. RPTR CAN EMAIL OR FAX A COPY OF THEIR OFFERING.

Description of Event or Problem · 1

ADDITIONAL INFO RECEIVED FROM MFR 10/09/02: THIS MEDWATCH SUBMISSION IS CLEARLY NOT A REPORT RELEVANT TO ANY "...SERIOUS ADVERSE EVENT, POTENTIAL/ACTUAL PRODUCT ERRORS AND/OR PRODUCT QUALITY PROBLEMS..." AS INTENDED BY FDA. IN FACT, MFR IS ACTUALLY UNCLEAR AS TO THE NATURE OF ANNOYANCE THE ANONYMOUS REPORTER IS COMPLAINING ABOUT; OTHER THAN PERHAPS HAVING RECEIVED A MAIL SOLICITATION FOR THE SALE OF MEDICAL EQUIPMENT. NORTH AMERICAN MEDICAL HAS U.S. DISTRIBUTORS FUNCTIONING UNDER VERY CLEAR DIRECTIVES AS TO MARKET CLAIMS. THEIR SPINA DEVICE IS CLEARLY STATED TO BE FDA COMPLIANT. DISTRIBUTORS WHO MARKET THIS DEVICE ARE ADDRESSING LICENSED MEDICAL DOCTORS. THESE DOCTORS WILL ALSO BE REFERRED TO INDEPENDENT STUDIES CITING CO'S EQUIPMENT AS BENEFICIAL IN A TREATMENT PROTOCOL FOR THE MANAGEMENT OF BACK PAIN STEMMING FROM A NUMBER OF UNDERLYING DIAGNOSES. DISTRIBUTORS ARE NOT RESTRICTED FROM CITING EQUIPMENT COSTS OR MEDICAL PRACTICE COST/REVENUE PROJECTIONS PROVIDED THEY FALL UNDER THE APPROPRIATE FTC GUIDELINES.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 SPINA SPINA ITH NORTH AMERICAN MEDICAL CORP * *

Patients

Seq Age Sex Outcome Treatment
1 *